Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2019

View Archived Issues

Microglia and AD

BRCA's effects range from indispensable to indifferent

Mimicking bone marrow keeps cultured blood stem cells quiescent

Polyphor closes phase III PRISM studies of murepavadin intravenous formulation

Positive topline data presented from phase IIb study of the TLPLDC vaccine

Recruitment ongoing in phase I/II study of FT-4101 in overweight/obese subjects with NASH

Tipepidine shows promise as a supplementary medication in children with ADHD

PledPharma reports results from POP phase I trial of calmangafodipir for paracetamol overdose

Results of exploratory analysis based on tumor location from phase II REACHIN study of regorafenib

Anti-SEMA4D antibody VX-15 may offer therapeutic potential for Alzheimer's disease

Intracutaneous zolmitriptan given high Migraine-ACT scores in clinical trial

Researchers test intranasal dantrolene for the treatment of Alzheimer's disease

X4 Pharmaceuticals patents CXCR4 antagonists

Bellus Health initiates phase II trial of BLU-5937 for unexplained or refractory chronic cough

Sterngreene presents new EGFR and HER2 inhibitors

Cyclerion Therapeutics synthesizes sGC activators

Presentation of data for PLX-R18 as prophylactic countermeasure for ARS

WHO declares Ebola outbreak in DRC a public health emergency of international concern

ChemoCentryx describes C5aR antagonists

Ribon Therapeutics discovers PARP14 inhibitors

Seelos submits IND for phase IIb/III study of SLS-005 for Sanfilippo syndrome

Cognitive and motor function enhanced by ASKT-4290 in aged mice

Apellis to develop APL-9 to target host responses to AAV vector administration

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...